The Latest Cardiac and Vascular News
Company builds on its expansion into deeper data analysis and predictive analytics REDWOOD CITY, Calif., Feb. 13, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has filed a 510(k) application for US FDA clearance for its next generation, advanced ECG analysis software. […]
EDEN PRAIRIE, Minn., Feb. 12, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the initiation of distribution agreements covering Germany, Austria and Switzerland with Neucomed Group and its affiliates, further expanding its commercial presence in the European Union. The company now has distribution partnerships covering 13 countries worldwide. […]
Operating expenses under control in a context of intensifying the European market access strategy Strong cash position of €55.5 million at December 31, 2019, providing financial visibility until mid-2021 Full FDA approval for a clinical feasibility study in the United States, with enrollment expected to begin in the fourth quarter […]
Vancouver, Feb. 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that the Company has […]
Medtech industry veteran of two IPOs on the Nasdaq Stock Market (HeartWare, Avedro) CLICHY, France–(BUSINESS WIRE)–CorWave, a medtech company focused on the development of an innovative Left Ventricular Assist Device (LVAD) to treat patients suffering from severe heart failure, announced today the election of Jim Schuermann to its board of […]
IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences. Additional participants in the financing included existing investors Andera […]
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Stephen Trowbridge to the role of Executive Vice President and Chief Financial Officer, effective February 5, 2020. Mr. Trowbridge has served as the […]
CALGARY, Alberta, Feb. 10, 2020 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) is pleased to announce the appointment of Dr. Ronnie Hershman, M.D., F.C.C.S., to its Board of Directors. Dr. Hershman is a successful, practicing cardiologist with over three decades of experience. Dr. Hershman […]
February 6, 2020 at 4:05 PM EST PDF Version BURLINGTON, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2019 results, provided guidance, and announced a $0.095/share dividend. Q4 2019 Results Record sales of $30.2mm, +6% (flat organic) vs. Q4 2018 Operating income […]
SUWANEE, GA, Feb. 07, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Dr. Tom Price to its Board of Directors. Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE. Dr. Price’s extensive experience in public service, serving the state of […]
